Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study in patients with dyslipidaemia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| GW677954 | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage change from baseline in non-HDL-C based on log-transformed data at week 24. |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage change from baseline in lipids, in Homeostasis Model Assessment-insulin sensitivity (HOMA-S), C-Reactive Protein (CRP), Fasting Plasma Glucose (FPG), body weight and waist circumference. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| GSK Clinical Trials | GlaxoSmithKline | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Buenos Aires | Buenos Aires | 1425 | Argentina | ||
| GSK Investigational Site |
Not provided
| Label | URL |
|---|---|
| Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research. | View source |
| ID | Type | URL | Comment |
|---|---|---|---|
| ADG103440 | Statistical Analysis Plan | View IPD |
Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Córdoba |
| Córdoba Province |
| 5000 |
| Argentina |
| GSK Investigational Site | Buenos Aires | Argentina |
| GSK Investigational Site | Córdoba | 5016 | Argentina |
| GSK Investigational Site | San Juan | 5400 | Argentina |
| GSK Investigational Site | Kippa-Ring | Queensland | 4021 | Australia |
| GSK Investigational Site | Meadowbrook | Queensland | 4131 | Australia |
| GSK Investigational Site | Elizabeth Vale | South Australia | 5112 | Australia |
| GSK Investigational Site | Keswick | South Australia | 5035 | Australia |
| GSK Investigational Site | Camperdown | Victoria | 2050 | Australia |
| GSK Investigational Site | Santiago | Región Metro de Santiago | 7510605 | Chile |
| GSK Investigational Site | Santiago | Región Metro de Santiago | 7571831 | Chile |
| GSK Investigational Site | San José | Costa Rica |
| GSK Investigational Site | Ahmedabad | 380 052 | India |
| GSK Investigational Site | Bangalore | 560 054 | India |
| GSK Investigational Site | Bangalore | 560034 | India |
| GSK Investigational Site | Chennai | 600 116 | India |
| GSK Investigational Site | Mumbai | 400008 | India |
| GSK Investigational Site | Riga | LV 1002 | Latvia |
| GSK Investigational Site | Riga | LV 1012 | Latvia |
| GSK Investigational Site | Riga | LV1005 | Latvia |
| GSK Investigational Site | Riga | LV1038 | Latvia |
| GSK Investigational Site | Durango | Durango | 34000 | Mexico |
| GSK Investigational Site | Pachuca | Hidalgo | 42039 | Mexico |
| GSK Investigational Site | Guadalajara | Jalisco | 44340 | Mexico |
| GSK Investigational Site | Mexico City | 11650 | Mexico |
| GSK Investigational Site | Auckland | 1311 | New Zealand |
| GSK Investigational Site | Christchurch | 8014 | New Zealand |
| GSK Investigational Site | Rotorua | 3201 | New Zealand |
| GSK Investigational Site | Karachi | 74800 | Pakistan |
| GSK Investigational Site | Lahore | 54000 | Pakistan |
| GSK Investigational Site | Brasov | 500366 | Romania |
| GSK Investigational Site | Bucharest | 020045 | Romania |
| GSK Investigational Site | Deva | 330084 | Romania |
| GSK Investigational Site | Moscow | 101990 | Russia |
| GSK Investigational Site | Moscow | 111020 | Russia |
| GSK Investigational Site | Moscow | 121 552 | Russia |
| GSK Investigational Site | S.-Petresburg | 195067 | Russia |
| GSK Investigational Site | Košice | 040 22 | Slovakia |
| GSK Investigational Site | Košice | 041 90 | Slovakia |
| GSK Investigational Site | Alicante | 03114 | Spain |
| GSK Investigational Site | Barcelona | 08022 | Spain |
| GSK Investigational Site | Barcelona | 08036 | Spain |
| GSK Investigational Site | Granada | 18003 | Spain |
| GSK Investigational Site | Granada | 18014 | Spain |
| GSK Investigational Site | Madrid | 28037 | Spain |
| GSK Investigational Site | Madrid | 28046 | Spain |
| GSK Investigational Site | Móstoles/Madrid | 28935 | Spain |
| GSK Investigational Site | Santiago de Compostela | 15706 | Spain |
| GSK Investigational Site | Tarrasa, Barcelona | 08221 | Spain |
For additional information about this study please refer to the GSK Clinical Study Register |
| ADG103440 | Clinical Study Report | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| ADG103440 | Individual Participant Data Set | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| ADG103440 | Dataset Specification | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| ADG103440 | Informed Consent Form | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| ADG103440 | Study Protocol | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| ADG103440 | Annotated Case Report Form | View IPD | For additional information about this study please refer to the GSK Clinical Study Register |
| ID | Term |
|---|---|
| D024821 | Metabolic Syndrome |
| D050171 | Dyslipidemias |
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D052439 | Lipid Metabolism Disorders |
Not provided
Not provided